Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Osteocalcin is a protein produced by bone-building osteoblasts, but it stays inactive until vitamin K dependent carboxylation adds calcium-binding sites to it, allowing calcium to be anchored into the bone matrix rather than left circulating. Vitamin K1 and vitamin K2 (menaquinones such as MK-4 and MK-7) serve as the essential cofactor for the enzyme gamma-glutamyl carboxylase, and when intake is low, undercarboxylated osteocalcin rises, which is associated with weaker bone mineralization and calcium depositing in soft tissue and arteries. Vitamin D increases osteocalcin production while vitamin K activates it, so the two nutrients work together, with magnesium, gut bacteria, dietary fat intake, and medications like warfarin all influencing how well the process works. There are several important details and individual factors to consider, including forms, absorption, and safety concerns, so see below for the complete answer.
If bone pain, easy fractures, dental issues, or fatigue prompted your interest in calcium and vitamin K, symptoms like these can stem from very different causes, and guessing rarely leads to the right next step, so take a few minutes for a free, instant, online symptom check to clarify what may be happening and how to move forward with the right care.
Last reviewed for medical accuracy: 08/18/2026
Healthy bones require more than just calcium and vitamin D. A lesser-known but crucial player is osteocalcin, a protein that binds calcium to the bone matrix. Vitamin K, especially vitamin K2 in its MK-4 and MK-7 forms, activates osteocalcin through a process called carboxylation. Here’s how this works—and why the choice between K2 MK-7 vs MK-4 for osteocalcin carboxylation matters.
Osteocalcin is a non‐collagenous protein produced by osteoblasts (bone-building cells). It serves as a “glue” that helps calcium ions become part of the hydroxyapatite crystals in bone.
Without sufficient carboxylation, osteocalcin remains underactive, leading to weaker bone mineralization and higher circulating levels of ucOC—an indicator of poor vitamin K status in bone.
Vitamin K acts as a cofactor for the enzyme gamma-glutamyl carboxylase, which converts specific glutamate residues on osteocalcin into gamma‐carboxyglutamate (Gla) residues. This conversion process:
When dietary vitamin K is low, this cycle slows, leaving more ucOC in circulation and less cOC in bone.
Vitamin K exists in two primary dietary forms:
Vitamin K2 comes in several subtypes (MK-n) based on the length of their isoprenoid side chain. The two most studied for osteocalcin activation are:
MK-4 (Menaquinone-4):
• Shorter side chain.
• Rapidly absorbed but quickly cleared from the bloodstream.
• Often used in pharmacological doses (45 mg/day) in clinical studies.
MK-7 (Menaquinone-7):
• Longer side chain.
• Higher absorption and much longer half-life (up to 72 hours).
• Effective at lower daily doses (90–180 µg).
| Feature | MK-4 | MK-7 |
|---|---|---|
| Bioavailability | Rapid absorption, short half-life | Slower absorption, long half-life |
| Daily Dose in Studies | 45,000 µg | 90–180 µg |
| Steady Serum Levels | Peaks quickly, then drops | More stable, sustained levels |
| Efficacy on cOC Levels | Improves carboxylation at high doses | Improves carboxylation at low doses |
| Tissue Distribution | Accumulates in tissues quickly | Distributed more uniformly |
MK-4 Studies
MK-7 Studies
Overall, MK-7’s longer half-life allows for once-daily dosing at a fraction of the dose used for MK-4, with equivalent—or in some cases superior—improvement in osteocalcin carboxylation and bone markers.
To support osteocalcin activation, consider a combination of dietary vitamin K1 and K2:
Typical supplemental doses:
Consult product labels and choose reputable brands that list the specific menaquinone subtype and dose.
Vitamin K2 is well tolerated. Key points:
To see if your symptoms might relate to vitamin deficiencies or bone health concerns, you can do a free, online symptom check, using the doctor approved Ubie Symptom Checker.
This overview is educational and not a substitute for medical advice. If you experience:
please speak to a doctor promptly. For any life-threatening or serious symptoms, seek immediate medical attention.
By understanding how vitamin K activates osteocalcin and choosing the right form—K2 MK-7 vs MK-4—you can support strong bones and long-term skeletal health.
(References)
* Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989 Jul;69(3):990-1047. doi: 10.1152/physrev.1989.69.3.990. PMID: 2664828.
* Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem. 1985;54:459-77. doi: 10.1146/annurev.bi.54.070185.002331. PMID: 3896125.
* Burnier JP, Borowski M, Furie BC, Furie B. Gamma-carboxyglutamic acid. Mol Cell Biochem. 1981 Sep 25;39:191-207. doi: 10.1007/BF00232574. PMID: 6458761.
* Shearer MJ. Vitamin K. Lancet. 1995 Jan 28;345(8944):229-34. doi: 10.1016/s0140-6736(95)90227-9. PMID: 7823718.
* Vermeer C, Thijssen HH, Hamulyák K. Vitamin K and tissue mineralization. Bibl Nutr Dieta. 2001;(55):159-70. doi: 10.1159/000059474. PMID: 11125573.
* Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013 Sep;24(9):2499-507. doi: 10.1007/s00198-013-2325-6. Epub 2013 Mar 23. PMID: 23525894.
* Kuang X, Liu C, Guo X, Li K, Deng Q, Li D. The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. Food Funct. 2020 Apr 30;11(4):3280-3297. doi: 10.1039/c9fo03063h. PMID: 32219282.
* Fusaro M, Cianciolo G, Brandi ML, Ferrari S, Nickolas TL, Tripepi G, Plebani M, Zaninotto M, Iervasi G, La Manna G, Gallieni M, Vettor R, Aghi A, Gasperoni L, Giannini S, Sella S, M Cheung A. Vitamin K and Osteoporosis. Nutrients. 2020 Nov 25;12(12). doi: 10.3390/nu12123625. Epub 2020 Nov 25. PMID: 33255760; PMCID: PMC7760385.
* Ma ML, Ma ZJ, He YL, Sun H, Yang B, Ruan BJ, Zhan WD, Li SX, Dong H, Wang YX. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials. Front Public Health. 2022;10:979649. doi: 10.3389/fpubh.2022.979649. Epub 2022 Aug 11. PMID: 36033779; PMCID: PMC9403798.
* Aaseth JO, Finnes TE, Askim M, Alexander J. The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review. Nutrients. 2024 Jul 25;16(15). doi: 10.3390/nu16152420. Epub 2024 Jul 25. PMID: 39125301; PMCID: PMC11313760.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.